{"count": 24, "results": [{"_id": "34434111", "pmid": 34434111, "pmcid": "PMC8381252", "title": "Metformin Attenuates Silica-Induced Pulmonary Fibrosis by Activating Autophagy via the AMPK-mTOR Signaling Pathway", "journal": "Front Pharmacol", "authors": ["Li SX", "Li C", "Pang XR", "Zhang J", "Yu GC", "Yeo AJ", "Lavin MF", "Shao H", "Jia Q", "Peng C"], "date": "2021-08-09T00:00:00Z", "doi": "10.3389/fphar.2021.719589", "meta_date_publication": "2021", "meta_volume": "12", "meta_issue": "", "meta_pages": "719589", "score": 50291.227, "text_hl": "A recent study found that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ can effectively reverse @CHEMICAL_Bleomycin @CHEMICAL_MESH:D001761 @@@bleomycin@@@-induced @<m>DISEASE_Pulmonary_Fibrosis</m> @DISEASE_MESH:D011658 @@@pulmonary fibrosis@@@, suggesting that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ has effects on @<m>DISEASE_Pulmonary_Fibrosis</m> @DISEASE_MESH:D011658 @@@idiopathic pulmonary interstitial fibrosis@@@. ", "citations": {"NLM": "Li SX, Li C, Pang XR, Zhang J, Yu GC, Yeo AJ, Lavin MF, Shao H, Jia Q, Peng C. Metformin Attenuates Silica-Induced Pulmonary Fibrosis by Activating Autophagy via the AMPK-mTOR Signaling Pathway Front Pharmacol. 2021;12():719589. PMID: 34434111", "BibTeX": "@article{34434111, title={Metformin Attenuates Silica-Induced Pulmonary Fibrosis by Activating Autophagy via the AMPK-mTOR Signaling Pathway}, author={Li SX and Li C and Pang XR and Zhang J and Yu GC and Yeo AJ and Lavin MF and Shao H and Jia Q and Peng C}, journal={Front Pharmacol}, volume={12}, pages={719589}}"}}, {"_id": "36147352", "pmid": 36147352, "pmcid": "PMC9485720", "title": "Effectiveness and mechanism of metformin in animal models of pulmonary fibrosis: A preclinical systematic review and meta-analysis", "journal": "Front Pharmacol", "authors": ["Wu X", "Xiao X", "Chen X", "Yang M", "Hu Z", "Shuai S", "Fu Q", "Yang H", "Du Q"], "date": "2022-09-06T00:00:00Z", "doi": "10.3389/fphar.2022.948101", "meta_date_publication": "2022", "meta_volume": "13", "meta_issue": "", "meta_pages": "948101", "score": 50281.305, "text_hl": "Effectiveness and mechanism of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ in animal models of @<m>DISEASE_Pulmonary_Fibrosis</m> @DISEASE_MESH:D011658 @@@pulmonary fibrosis@@@: A preclinical systematic review and meta-analysis", "citations": {"NLM": "Wu X, Xiao X, Chen X, Yang M, Hu Z, Shuai S, Fu Q, Yang H, Du Q. Effectiveness and mechanism of metformin in animal models of pulmonary fibrosis: A preclinical systematic review and meta-analysis Front Pharmacol. 2022;13():948101. PMID: 36147352", "BibTeX": "@article{36147352, title={Effectiveness and mechanism of metformin in animal models of pulmonary fibrosis: A preclinical systematic review and meta-analysis}, author={Wu X and Xiao X and Chen X and Yang M and Hu Z and Shuai S and Fu Q and Yang H and Du Q}, journal={Front Pharmacol}, volume={13}, pages={948101}}"}}, {"_id": "34399790", "pmid": 34399790, "pmcid": "PMC8365894", "title": "Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling", "journal": "J Transl Med", "authors": ["Cheng D", "Xu Q", "Wang Y", "Li G", "Sun W", "Ma D", "Zhou S", "Liu Y", "Han L", "Ni C"], "date": "2021-08-16T00:00:00Z", "doi": "10.1186/s12967-021-03036-5", "meta_date_publication": "2021 Aug 16", "meta_volume": "19", "meta_issue": "1", "meta_pages": "349", "score": 50277.3, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ attenuates @CHEMICAL_Silicon_Dioxide @CHEMICAL_MESH:D012822 @@@silica@@@-induced @<m>DISEASE_Pulmonary_Fibrosis</m> @DISEASE_MESH:D011658 @@@pulmonary fibrosis@@@ via @GENE_PRKAB1 @GENE_5564 @@@AMPK@@@ signaling", "citations": {"NLM": "Cheng D, Xu Q, Wang Y, Li G, Sun W, Ma D, Zhou S, Liu Y, Han L, Ni C. Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling J Transl Med. 2021 Aug 16;19(1):349. PMID: 34399790", "BibTeX": "@article{34399790, title={Metformin attenuates silica-induced pulmonary fibrosis via AMPK signaling}, author={Cheng D and Xu Q and Wang Y and Li G and Sun W and Ma D and Zhou S and Liu Y and Han L and Ni C}, journal={J Transl Med}, volume={19}, number={1}, pages={349}}"}}, {"_id": "36817136", "pmid": 36817136, "pmcid": "PMC9936158", "title": "Metformin attenuates fibroblast activation during pulmonary fibrosis by targeting S100A4 via AMPK-STAT3 axis ", "journal": "Front Pharmacol", "authors": ["Ji H", "Dong H", "Lan Y", "Bi Y", "Gu X", "Han Y", "Yang C", "Cheng M", "Gao J"], "date": "2023-02-03T00:00:00Z", "doi": "10.3389/fphar.2023.1089812", "meta_date_publication": "2023", "meta_volume": "14", "meta_issue": "", "meta_pages": "1089812", "score": 50274.043, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ attenuates fibroblast activation during @<m>DISEASE_Pulmonary_Fibrosis</m> @DISEASE_MESH:D011658 @@@pulmonary fibrosis@@@ by targeting @GENE_S100A4 @GENE_6275 @@@S100A4@@@ via @GENE_PRKAB1 @GENE_5564 @@@AMPK@@@-@GENE_STAT3 @GENE_6774 @@@STAT3@@@ axis ", "citations": {"NLM": "Ji H, Dong H, Lan Y, Bi Y, Gu X, Han Y, Yang C, Cheng M, Gao J. Metformin attenuates fibroblast activation during pulmonary fibrosis by targeting S100A4 via AMPK-STAT3 axis  Front Pharmacol. 2023;14():1089812. PMID: 36817136", "BibTeX": "@article{36817136, title={Metformin attenuates fibroblast activation during pulmonary fibrosis by targeting S100A4 via AMPK-STAT3 axis }, author={Ji H and Dong H and Lan Y and Bi Y and Gu X and Han Y and Yang C and Cheng M and Gao J}, journal={Front Pharmacol}, volume={14}, pages={1089812}}"}}, {"_id": "38286745", "pmid": 38286745, "pmcid": "PMC10794892", "title": "Metformin enhanced the effect of pirfenidone on pulmonary fibrosis in mice", "journal": "Clin Respir J", "authors": ["Liu N", "Song Y", "Liu T", "Wang H", "Yu N", "Ma H"], "date": "2024-01-01T00:00:00Z", "doi": "10.1111/crj.13731", "meta_date_publication": "2024 Jan", "meta_volume": "18", "meta_issue": "1", "meta_pages": "e13731", "score": 50272.332, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ enhanced the effect of @CHEMICAL_pirfenidone @CHEMICAL_MESH:C093844 @@@pirfenidone@@@ on @<m>DISEASE_Pulmonary_Fibrosis</m> @DISEASE_MESH:D011658 @@@pulmonary fibrosis@@@ in mice", "citations": {"NLM": "Liu N, Song Y, Liu T, Wang H, Yu N, Ma H. Metformin enhanced the effect of pirfenidone on pulmonary fibrosis in mice Clin Respir J. 2024 Jan;18(1):e13731. PMID: 38286745", "BibTeX": "@article{38286745, title={Metformin enhanced the effect of pirfenidone on pulmonary fibrosis in mice}, author={Liu N and Song Y and Liu T and Wang H and Yu N and Ma H}, journal={Clin Respir J}, volume={18}, number={1}, pages={e13731}}"}}, {"_id": "37058092", "pmid": 37058092, "title": "Inhaled Lipid Nanoparticles Alleviate Established Pulmonary Fibrosis.", "journal": "Small", "authors": ["Li D", "Zhao A", "Zhu J", "Wang C", "Shen J", "Zheng Z", "Pan F", "Liu Z", "Chen Q", "Yang Y"], "date": "2023-04-14T00:00:00Z", "doi": "10.1002/smll.202300545", "meta_date_publication": "2023 Apr 14", "meta_volume": "", "meta_issue": "", "meta_pages": "e2300545", "score": 50267.59, "text_hl": "Herein, inhalable liposomes encapsulating @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, a first-line antidiabetic drug that has been reported to effectively reverse @<m>DISEASE_Pulmonary_Fibrosis</m> @DISEASE_MESH:D011658 @@@pulmonary fibrosis@@@ by modulating multiple metabolic pathways, and @CHEMICAL_nintedanib @CHEMICAL_MESH:C530716 @@@nintedanib@@@, a well-known antifibrotic drug that has been widely used in the clinic, are developed for @<m>DISEASE_Pulmonary_Fibrosis</m> @DISEASE_MESH:D011658 @@@pulmonary fibrosis@@@ treatment. ", "citations": {"NLM": "Li D, Zhao A, Zhu J, Wang C, Shen J, Zheng Z, Pan F, Liu Z, Chen Q, Yang Y. Inhaled Lipid Nanoparticles Alleviate Established Pulmonary Fibrosis. Small. 2023 Apr 14;():e2300545. PMID: 37058092", "BibTeX": "@article{37058092, title={Inhaled Lipid Nanoparticles Alleviate Established Pulmonary Fibrosis.}, author={Li D and Zhao A and Zhu J and Wang C and Shen J and Zheng Z and Pan F and Liu Z and Chen Q and Yang Y}, journal={Small}, pages={e2300545}}"}}, {"_id": "34727651", "pmid": 34727651, "title": "[Interventional effect of metformin on pulmonary inflammation and pulmonary fibrosis in silicotic rats].", "journal": "Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi", "authors": ["Li SX", "Pang XR", "Yan HY", "Zhang J", "Jia Q", "Li C", "Shao H", "Yu GC"], "date": "2021-10-20T00:00:00Z", "doi": "10.3760/cma.j.cn121094-20200930-00552", "meta_date_publication": "2021 Oct 20", "meta_volume": "39", "meta_issue": "10", "meta_pages": "726-732", "score": 50266.176, "text_hl": "[Interventional effect of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ on @DISEASE_Pneumonia @DISEASE_MESH:D011014 @@@pulmonary inflammation@@@ and @<m>DISEASE_Pulmonary_Fibrosis</m> @DISEASE_MESH:D011658 @@@pulmonary fibrosis@@@ in silicotic @SPECIES_10116 @@@rats@@@].", "citations": {"NLM": "Li SX, Pang XR, Yan HY, Zhang J, Jia Q, Li C, Shao H, Yu GC. [Interventional effect of metformin on pulmonary inflammation and pulmonary fibrosis in silicotic rats]. Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2021 Oct 20;39(10):726-732. PMID: 34727651", "BibTeX": "@article{34727651, title={[Interventional effect of metformin on pulmonary inflammation and pulmonary fibrosis in silicotic rats].}, author={Li SX and Pang XR and Yan HY and Zhang J and Jia Q and Li C and Shao H and Yu GC}, journal={Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi}, volume={39}, number={10}, pages={726-732}}"}}, {"_id": "34450310", "pmid": 34450310, "title": "Activated AMPK by metformin protects against fibroblast proliferation during pulmonary fibrosis by suppressing FOXM1.", "journal": "Pharmacol Res", "authors": ["Gu X", "Han YY", "Yang CY", "Ji HM", "Lan YJ", "Bi YQ", "Zheng C", "Qu J", "Cheng MH", "Gao J"], "date": "2021-11-01T00:00:00Z", "doi": "10.1016/j.phrs.2021.105844", "meta_date_publication": "2021 Nov", "meta_volume": "173", "meta_issue": "", "meta_pages": "105844", "score": 50262.098, "text_hl": "Activated @GENE_PRKAB1 @GENE_5564 @@@AMPK@@@ by @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ protects against fibroblast proliferation during @<m>DISEASE_Pulmonary_Fibrosis</m> @DISEASE_MESH:D011658 @@@pulmonary fibrosis@@@ by suppressing @GENE_FOXM1 @GENE_2305 @@@FOXM1@@@.", "citations": {"NLM": "Gu X, Han YY, Yang CY, Ji HM, Lan YJ, Bi YQ, Zheng C, Qu J, Cheng MH, Gao J. Activated AMPK by metformin protects against fibroblast proliferation during pulmonary fibrosis by suppressing FOXM1. Pharmacol Res. 2021 Nov;173():105844. PMID: 34450310", "BibTeX": "@article{34450310, title={Activated AMPK by metformin protects against fibroblast proliferation during pulmonary fibrosis by suppressing FOXM1.}, author={Gu X and Han YY and Yang CY and Ji HM and Lan YJ and Bi YQ and Zheng C and Qu J and Cheng MH and Gao J}, journal={Pharmacol Res}, volume={173}, pages={105844}}"}}, {"_id": "32269725", "pmid": 32269725, "title": "Metformin ameliorates bleomycin-induced pulmonary fibrosis in mice by suppressing IGF-1.", "journal": "Am J Transl Res", "authors": ["Xiao H", "Huang X", "Wang S", "Liu Z", "Dong R", "Song D", "Dai H"], "date": "2020-03-15T00:00:00Z", "meta_date_publication": "2020", "meta_volume": "12", "meta_issue": "3", "meta_pages": "940-949", "score": 50260.66, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@ ameliorates @CHEMICAL_Bleomycin @CHEMICAL_MESH:D001761 @@@bleomycin@@@-induced @<m>DISEASE_Pulmonary_Fibrosis</m> @DISEASE_MESH:D011658 @@@pulmonary fibrosis@@@ in @SPECIES_10090 @@@mice@@@ by suppressing @GENE_IGF1 @GENE_16000 @@@IGF-1@@@.", "citations": {"NLM": "Xiao H, Huang X, Wang S, Liu Z, Dong R, Song D, Dai H. Metformin ameliorates bleomycin-induced pulmonary fibrosis in mice by suppressing IGF-1. Am J Transl Res. 2020;12(3):940-949. PMID: 32269725", "BibTeX": "@article{32269725, title={Metformin ameliorates bleomycin-induced pulmonary fibrosis in mice by suppressing IGF-1.}, author={Xiao H and Huang X and Wang S and Liu Z and Dong R and Song D and Dai H}, journal={Am J Transl Res}, volume={12}, number={3}, pages={940-949}}"}}, {"_id": "40929956", "pmid": 40929956, "title": "Metformin attenuates coal dust nanoparticle-induced pulmonary fibrosis by modulating inflammation and epithelial-mesenchymal transition.", "journal": "Int Immunopharmacol", "authors": ["Zhang Y", "Huang Y", "Ding M", "Zhang S", "Liu X", "Zhou S"], "date": "2025-09-09T00:00:00Z", "doi": "10.1016/j.intimp.2025.115497", "meta_date_publication": "2025 Sep 9", "meta_volume": "165", "meta_issue": "", "meta_pages": "115497", "score": 50260.426, "text_hl": "Here, we explored the antifibrotic effects of @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Met@@@) in CD-nanoparticle (CD-NP)-induced @<m>DISEASE_Pulmonary_Fibrosis</m> @DISEASE_MESH:D011658 @@@PF@@@, focusing on its preventive and therapeutic potential. ", "citations": {"NLM": "Zhang Y, Huang Y, Ding M, Zhang S, Liu X, Zhou S. Metformin attenuates coal dust nanoparticle-induced pulmonary fibrosis by modulating inflammation and epithelial-mesenchymal transition. Int Immunopharmacol. 2025 Sep 9;165():115497. PMID: 40929956", "BibTeX": "@article{40929956, title={Metformin attenuates coal dust nanoparticle-induced pulmonary fibrosis by modulating inflammation and epithelial-mesenchymal transition.}, author={Zhang Y and Huang Y and Ding M and Zhang S and Liu X and Zhou S}, journal={Int Immunopharmacol}, volume={165}, pages={115497}}"}}]}